Evaluations of imidazolium ionic liquids as novel skin permeation enhancers for drug transdermal delivery

Evaluations of imidazolium ionic liquids as novel skin permeation enhancers for drug transdermal delivery

Authors: Zhang D, Wang H, Cui X, Wang C
Publication: Pharm Dev Technol

In this work, imidazolium ionic liquids (imidazolium ILs) were employed as the novel chemical permeation enhancers (CPEs) and their performances and mechanisms of action were deeply investigated.

Identification of Novel Potential Inhibitors of Aldose Reductase: A Multistage Computational Filtering Approach

Identification of Novel Potential Inhibitors of Aldose Reductase: A Multistage Computational Filtering Approach

Publication: Recent Advance in Diabetes Treatment
Software: ADMET Predictor®

The aldose reductase (AR) is a rate limiting enzyme in the polyol pathway, for the conversion of glucose to sorbitol. The identification of a potent inhibitor is the need of the hour.

A Workflow to Investigate Exposure and Pharmacokinetic Influences on High-Throughput in Vitro Chemical Screening Based on Adverse Outcome Pathways

A Workflow to Investigate Exposure and Pharmacokinetic Influences on High-Throughput in Vitro Chemical Screening Based on Adverse Outcome Pathways

Publication: Environ Health Perspect
Software: ADMET Predictor®

Adverse outcome pathways (AOPs) link adverse effects in individuals or populations to a molecular initiating event (MIE) that can be quantified using in vitro methods.

Comparison of biorelevant simulated media mimicking the intestinal environment to assess the solubility profiles of poorly soluble drugs

Comparison of biorelevant simulated media mimicking the intestinal environment to assess the solubility profiles of poorly soluble drugs

Publication: Pharm Dev Technol
Software: GastroPlus®

During the discovery stage in lead identification/optimization, compounds are characterized for their solubilities in biorelevant media and these data are often used to model the in vivo behavior of...

Using Physiologically Based Pharmacokinetic Modeling for in vitro – in vivo Extrapolation to Predict Chemical Exposure

Using Physiologically Based Pharmacokinetic Modeling for in vitro – in vivo Extrapolation to Predict Chemical Exposure

Division: PBPK

Mechanistic absorption and physiologically based pharmacokinetic (MA/ PBPK) models are useful tools in risk assessment. These models incorporate complex processes related to a compound’s disposition...

Solidified SNEDDS of loratadine: Formulation using hydrophilic and hydrophobic grades of Aerosil®, pharmacokinetic evaluations and in vivo-in silico predictions using GastroPlus

Solidified SNEDDS of loratadine: Formulation using hydrophilic and hydrophobic grades of Aerosil®, pharmacokinetic evaluations and in vivo-in silico predictions using GastroPlus

Publication: RSC Adv
Software: GastroPlus®

In the present study, hydrophilic and hydrophobic grades of Aerosil® were employed as adsorbents to develop a solid self-nanoemulsifying drug delivery system (S-SNEDDS) of loratadine and were...

A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets

A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets

Publication: Drug Dev Ind Pharm
Software: GastroPlus®

Preclinical species are a crucial component of drug development, but critical differences in physiology and anatomy need to be taken into account when attempting to extrapolate to humans or between species.

The potential of immobilized artificial membrane chromatography to predict human oral absorption

The potential of immobilized artificial membrane chromatography to predict human oral absorption

Publication: Eur J Pharm Sci

The potential of immobilized artificial membrane (IAM) chromatography to estimate human oral absorption (%HOA) was investigated.

Elucidating Differences in the Hepatotoxic Potential of Tolcapone and Entacapone With DILIsym(®), a Mechanistic Model of Drug-Induced Liver Injury.

Elucidating Differences in the Hepatotoxic Potential of Tolcapone and Entacapone With DILIsym(®), a Mechanistic Model of Drug-Induced Liver Injury.

Publication: CPT Pharmacometrics Syst Pharmacol
Software: DILIsym®

Tolcapone and entacapone are catechol-O-methyltransferase (COMT) inhibitors developed as adjunct therapies for treating Parkinson's disease.

Biomarker exposure-response relationships as the basis for rational dose selection: Lessons from a simulation exercise using a selective COX-2 inhibitor

Biomarker exposure-response relationships as the basis for rational dose selection: Lessons from a simulation exercise using a selective COX-2 inhibitor

Publication: J Clin Pharmacol
Division: PBPK

An exposure-response model was used to characterize the pharmacokinetic-pharmacodynamic relationship of GW406381, a COX-2 inhibitor, based on data from ex vivo...